Pancreatic Cancer Action Network Fellowship

The Pancreatic Cancer Action Network offers various research grants aimed at advancing the study and treatment of pancreatic cancer. These grants are part of a broader initiative to support researchers at different stages of their careers and to foster innovative approaches to tackling this challenging disease. The network is a 501(c)(3) nonprofit organization, and contributions to it are tax-deductible as permitted by law. One of the funding opportunities is the Pancreatic Cancer Action Network Fellowship, funded by the Francois Wallace Monahan Fund. This fellowship provides $175,000 over two years to support a graduate student, postdoctoral fellow, or medical resident of French nationality who is part of a project team already receiving a PanCAN grant. The purpose is to advance developing research in pancreatic cancer. The application deadline for this fellowship has closed. Another opportunity is the 2023 Pancreatic Cancer Action Network Career Development Award, which offers $250,000 over two years. This award is designed for junior faculty members to conduct research in pancreatic cancer and establish successful career paths in the field. The research can be basic, translational, clinical, or epidemiological, as long as it is directly applicable to pancreatic cancer. Special consideration is given to projects in understudied areas, minority researchers, and those focusing on cancer health disparities. The application deadline for this award has also closed. The 2023 PanCAN Cancer Informatics & Data Science Research Fellowship is another grant opportunity, aimed at predoctoral students or postdoctoral fellows. This fellowship supports the application of computational and data science methods to pancreatic cancer research, leveraging patient health data from the SPARK platform. The fellowship covers stipend and research-related costs over two years. The application deadline for this fellowship has closed. Additionally, the 2023 PanCAN Therapeutic Accelerator Award offers up to $5,000,000 to a pharmaceutical or biotechnology company to support early-stage clinical trials for pancreatic ductal adenocarcinoma. This award aims to offset testing costs in Phase I/II trials. The application deadline for this award has also closed. Grantees of these programs become part of PanCAN's Community for Progress, which provides mentorship and ongoing career support. This community connects grantees with leading scientists and offers professional development opportunities to keep researchers committed and engaged in the field. For more information, potential applicants can contact grants@pancan.org or call (310) 725-0025. The Pancreatic Cancer Action Network is located at 2101 Rosecrans Ave, Suite 3200, El Segundo, CA 90245.